The Global Radiation-Induced Myelosuppression Treatment Industry is experiencing a remarkable surge, with projected sales reaching a substantial US$ 2.9 Billion in 2022. According to the latest insights unveiled by Future Market Insights (FMI), this thriving market is set to maintain its upward trajectory, fuelled by a steady Compound Annual Growth Rate (CAGR) of 3.1%. Radiation-induced …